My body feels better all around, and I have more energy, even my workouts seem easier to recover from. I had a traumatic ski accident and started BPC-157 (part of the KLOW stack)
So now I aim for something small every few hours
Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, Fat and colleagues compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin
Suspected side effects can be reported via the MHRA Yellow Card scheme (yellowcard
At the same time, GLP-1RAs may reduce central responses to cues associated with energy-dense foods, thereby lowering cue-triggered motivational drive (wanting) (5, 60)